The main similarity that both articles highlight is the topic of morals. “What is morally correct?” I can imagine if they could sit down to talk about their work they would come to a common ground in their beliefs. Steve Buist’s article highlights the unethical behavior between researchers and companies that fund researches, and how these behaviors can be improved. “Improving the transparency around the financial relationships between researchers and companies is one way to deal with the potential conflicts of interest that can arise” (Buist, S., 2012). One such example is the “most reputable scientific journals, such as the New England Journal of Medicine, now require the authors of scientific papers to make detailed disclosure of their commercial financial relationships as a prerequisite for publication” (Buist, S., 2012).
Business Law 19 February 2011 Ethics in the Pharmaceutical Industry The pharmaceutical industry is a high profile industry that is in the news a lot concerning its ethics. This could be from the sheer size of the industry, because people can relate through the use of the industry’s products, the importance of people’s health or the pharmaceutical industry dances on the line of profits and good ethics. In this paper, I am going to dig deeper to uncover some of the Industry’s behaviors and the reasons behind their actions. Let’s discover if those actions are in good faith or a deceitful way to increase revenue. Any industry is not without its own isolated illegal and unethical behavior.
Political competence is what can really make the CC part of it shine and in turn CC will make political competence shine. Political competence is one of the skills necessary to apply good cooperate citizenship. Both are related to ethics. Whereas good corporate citizenship is about an organization acting ethically toward society as a whole, political competence is one of the necessary skill required to apply good cooperate citizenship, which is a number of related skills. Good CC, for example, a company CEO of a HCO defines good corporate citizenship as meeting the growth and demands placed on health companies by society in an economically, environmentally and socially responsible manner (“The Power to Change: Mobilizing board leadership to deliver sustainable value to markets and society”, 2001).
The question I ask here today is this ok? Is it ok if these companies are allowed to persuade our doctors to sell us one drug over another? And if so, do we know if our doctors and the sale reps putting our best interests here ahead of their own interest? To better help us to understand a little more of what happens in the Pharma industry, here I have a sample writing from Ben Goldacre new book Big Pharma. Drugs are tested by the people
With Cad Mex Pharma’s; as with any global business there are always ethical dilemmas. As far as the viral spread; the average thoughts of a person is to help stop an epidemic. However; as a business person the bottom line and the legal side has to be looked at. After all if the company responsible for the vaccine or cure is not in business there will be no one saved. This is where knowing the laws and choosing the best business decisions comes into play.
Why are ethical behaviour and government regulations important to marketing? Ethical behaviour is used within many businesses to ensure the business provides accurate information to customers as well as other businesses to engage in fair competition. It is important for a business to have ethical behaviour in relation to the marketing side of the business so that goods produced, promoted then sold do not provide misleading information. If identified by consumers, it can have a major impact on all functions of the business as it has the potential to ruin the business’s reputation placing the business at a declining stage of the business’s life cycle. In a similar manner government regulations are also important and must be overviewed by all functions of a
Pharma Care Ethics and Corporate Responsibilities Andrea Staton Strayer University ELLEN KAPALKO May 25, 2015 Pharma Care Ethics and Corporate Responsibilities Numerous people do not know the full story about their pharmaceutical companies in place of a well-known problem involving unpublished influence, according to mounting the evidence. Often, medical journals that patronize research will make statements only "active" results leaving out the findings of false results where an original drug or wok experience may have been upheld more hurtful than help. The new study of the difficult points to hidden or misrepresentation for all sorts of conditions. Meanwhile, modern pharmaceutical companies like Pharma Care ethical treatment of workers in a foreign country factory is beyond cruel and cold-hearted. The large manufacturing facility in the African nation of Calabria, which is own by Pharma Care.
In some cases off-label uses often exceed the intended use, which in turn becomes very profitable for the pharmaceutical manufacturer. “In 2004, sales of the drug peaked at $2.7 billion. But that same year Pfizer was found to be urging physicians to prescribe Neurontin for off-label uses, which is illegal. As a result, the company had to pay $430 million in criminal fines and civilian penalties.” (Arellano, 2013). Since it would be beneficial to companies to get approval from the Federal Drug Administration (FDA), companies will conduct research studies on the effects of these other conditions.
As we age and the population is constantly change, we the people are more effectuated to our health especially as the technology and social media are the new living standards. As the standard are chaning the, pharmaceutical companies play a significant role in promoting good health. If we are governed to obi by rules and regulation, then it necessary for the Pharmaceutical companies to live up ethical principles and corporate social responsibilities. Although, we tend to turn the blind eye there is tons of violations in pharmaceutical industry that money continues to cover up. This will lead us into a case where, Pfizer failed to keep its commitment to corporate social responsibility as one of the most successful pharmaceutical companies, the choice they made to choose to bear unethical behavior in 1996.
Healthcare Regulatory Agencies and their Effect on Rising Medical Costs Regulatory agencies can be viewed as a hindrance, these agencies such as the Food and Drug Administration (FDA), Joint Commission of Accreditation of Hospitals (JOINT), and the Occupational Safety and Healthcare Administration (OSHA) are responsible for much of the increase in costs that have taken place in providing effective and safe healthcare in the past decade. There have been arguments ever since the inception of the first regulatory agency as to whether or not these were, or would be advantageous to healthcare practitioners and healthcare institutions. Although their focus is on the patient, these agencies state that they exist for the healthcare provider’s protection. There is solid evidence demonstrating the rise in costs due to these regulations. Regulations can be as complex as safety devices for injections and as simple as requiring hair covering for healthcare workers.